{"id":17,"date":"2014-06-30T02:06:51","date_gmt":"2014-06-30T01:06:51","guid":{"rendered":"http:\/\/charity.skat.tf\/?page_id=13"},"modified":"2020-10-13T10:06:07","modified_gmt":"2020-10-13T09:06:07","slug":"home","status":"publish","type":"page","link":"https:\/\/www.stargardt.fr\/en\/","title":{"rendered":"Stargardt Foundation"},"content":{"rendered":"
<\/div>
<\/div>\n
\n

Stargardt Foundation\u00a0:<\/strong><\/h1>\n

Work hand in hand with research<\/strong><\/h1>\n

The Stargardt Foundation groups and federates people with Stargardt disease in order to dymamise medical research and facilitate the development of new\u00a0 treatments\u00a0 with the aim of stopping the disease and restore vision.<\/p>\n

Created in 2013 by Denis Cayet, \u00a0french Contractor in Innovating Projects, the Stargardt Foundation wishes to establish an activ interaction between patients with Stargardt disease, carriers of muting ABCA4 gene, and the world of scientific research.<\/p>\n

The Foundation collaborates with internationaly reknown teams of researchers in ophtalmology, biology, gene and cell therapy, and hospital departments.<\/p>\n

Searches and carriers of the Stargardt disease make the heart of the foundation.<\/strong><\/p>\n

 <\/p>\n

2017\u00a0: The Stargardt FOUNDATION COMMITS in research<\/h2>\n

In 2017, in connection with RETINA France, Stargardt Foundation continues to\u00a0subsidize basic research in pharmacology \u00a0worn by French teams.<\/p>\n

<\/div>

\n

\"Denis<\/a><\/p>\n

<\/div>

<\/div> <\/div>\n

<\/div>\n

OUR AIMS\u00a0<\/strong><\/h2>\n
<\/div>\n
\n\"f\u00e9d\u00e9rer\"<\/p>\n

FEDERATE<\/strong><\/h2>\n

Create a community of patients with Stargardt disease.<\/p>\n<\/div>\n

\n\"informer\"<\/p>\n

INFORM<\/strong><\/h2>\n

Give clear and exhaustive information on Stargardt disease.<\/p>\n<\/div>\n

\n\"soutenir\"<\/p>\n

SUPPORT<\/strong><\/h2>\n

Support medical research and create a partnership with scientific teams.<\/p>\n<\/div>\n

\n\"participer\"<\/p>\n

RAISE FUNDS <\/strong><\/h2>\n

Raise funds to support Stargardt research.<\/p>\n<\/div>

<\/div>\n<\/div>\n

<\/div>
\n

<\/div>\n
\n

RESEARCH AND\u00a0 CURRENT TESTS<\/strong><\/h2>\n
<\/div>\n
\n

Gene therapy<\/strong><\/h3>\n

In the\u00a0 treatment of\u00a0 orphan diseases, the aim of gene therapy is to introduce in a patient\u00a0 with genetic mutation, the copy of the normal gene or of the modified gene responsible for deficiency.<\/p>\n

Learn more\u00a0<\/strong>><\/a>
\n<\/div>\n

\n

Pharmacology<\/strong><\/h3>\n

Scientifics are studying the adaptation of drug molecules with an interaction on direct or indirect molecular mecanisms of vision process.<\/p>\n

Learn more\u00a0<\/strong>><\/a>
\n<\/div>\n

\n

Cell therapy<\/strong><\/h3>\n

The evoluation of the Stargardt disease results in deterioration and death of the photorecptors in the\u00a0macula. Cell therapy is one of the actual areas of research.<\/p>\n

Learn more<\/strong> ><\/a>
\n<\/div>\n

\n

The artificial retina<\/strong><\/h3>\n

The artificial retina is a prosthesis installed to compensate the loss and the dysfunction of photoreceptors.<\/p>\n

Learn more\u00a0><\/strong><\/a>
\n<\/div>

<\/div>\n<\/div>\n
\"Share<\/a>